Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Dasiglucagon for Hypoglycemia in T1D
NCT04764968Phase 2Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Apr 2021
- Primary completion
- Dec 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dasiglucagon in hypoglycemia, sponsored by Steno Diabetes Center Copenhagen. Started Apr 2021; status: completed.
02
Drugs
dasiglucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT04764968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04764968.